why choose us

First received: October 04, 2023

Clinical Trial: DTA-2: Dopaminergic Therapy for Anhedonia - 2

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Anhedonia

Study Type: INTERVENTIONAL


Official Title: Dopaminergic Therapy for Inflammation-Related Anhedonia in Depression - 2

Brief Summary: The purpose of this 8-week, double-blind, placebo-controlled, study is to explore new treatment options for people with depression who have high inflammation and anhedonia.Seventy male and female participants with depression, between 25-55 years of age, with higher levels of inflammation and anhedonia will be randomized to receive L-DOPA or matched placebo over 8 weeks.Participants will complete lab tests, medical and psychiatric assessments, motivation and motor tasks, and MRI scans as part of the study.The total…

Read more